![David Moller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Moller
Plus aucun poste en cours
Profil
David E.
Moller is currently an Independent Non-Executive Director at Eccogene, Inc. since 2024, an Independent Non-Executive Director at Variant Bio, Inc. starting in 2025, and a Venture Partner at Third Rock Ventures LLC starting in 2025.
Former positions include Vice President-Endocrine & Cardiovascular Research at Eli Lilly & Co., Vice President-Metabolic Disorders at Merck & Co., Inc., Chief Scientific Officer & Executive VP at Poxel SA, Chief Scientific Officer at Sigilon Therapeutics, Inc. from 2018 to 2020, Assistant Professor at Harvard Medical School, and Vice President at Merck Research Laboratories Massachusetts LLC.
Education includes an undergraduate degree from Brown University conferred in 1978 and a doctorate from The University of Cincinnati College of Medicine conferred in 1983.
Postes actifs de David Moller
| Sociétés | Poste | Début |
|---|---|---|
Variant Bio, Inc.
 Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Directeur/Membre du Conseil | 01/06/2025 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01/06/2025 |
Anciens postes connus de David Moller
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de David Moller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
The University of Cincinnati College of Medicine
 The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Variant Bio, Inc.
Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Health Technology |
